Contributed by: Dennis Fortier, President, Medical Care Corporation
________________________________________________
As new agents for the treatment of Alzheimer's disease move through the pipeline of clinical trial, we try to highlight milestones and announcements to keep you informed. We have written several times about Dimebon which is one of the most promising agents currently under development.
As pointed out recently by readers in Australia, the Dimebon trial is now enrolling patients down under. More information about that activity can be gathered through the Dimebon Australian Study blog.
Subscribe to:
Post Comments
(
Atom
)
Posts
Thank you so much for adding our blog! The trial is now open calling for participants, so people who want to find out more about eligibilty and enrolment can call the free hot-line here in AU 1-800-235-526.
ReplyDelete